Gene · 4359
Papers1,500
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 1,500
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Conserved intramolecular networks in GDAP1 are closely connected to CMT-linked mutations and protein stability. | PLoS One | 2023 | 37058526 | PubTator, text mining | PubMed |
| Schwann Cells Are Key Regulators of Corneal Epithelial Renewal. | Invest Ophthalmol Vis Sci | 2023 | 37036418 | PubTator, text mining | PubMed |
| Pediatric Crohn's disease diagnosis aid via genomic analysis and machine learning. | Front Pediatr | 2023 | 37033178 | PubTator, text mining | PubMed |
| Effects of prenatal pesticide exposure on the fetal brain and placenta transcriptomes in a rodent model. | Toxicology | 2023 | 37019170 | PubTator, text mining | PubMed |
| Culture Conditions for Human Induced Pluripotent Stem Cell-Derived Schwann Cells: A Two-Centre Study. | Int J Mol Sci | 2023 | 36982441 | PubTator, text mining | PubMed |
| Complete Loss of Myelin protein zero (MPZ) in a patient with a late onset Charcot-Marie-Tooth (CMT). | Metab Brain Dis | 2023 | 36952089 | PubTator, text mining | PubMed |
| Characterization of immature ovarian teratomas through single-cell transcriptome. | Front Immunol | 2023 | 36936909 | PubTator, text mining | PubMed |
| Mechanisms and treatment strategies of demyelinating and dysmyelinating Charcot-Marie-Tooth disease. | Neural Regen Res | 2023 | 36926710 | PubTator, text mining | PubMed |
| Transcriptomic profile comparison reveals conservation of ionocytes across multiple organs. | Sci Rep | 2023 | 36864051 | PubTator, text mining | PubMed |
| Multi-organ single-cell analysis reveals an on/off switch system with potential for personalized treatment of immunological diseases. | Cell Rep Med | 2023 | 36858042 | PubTator, text mining | PubMed |
| Molecular mechanisms of atrazine toxicity on H19-7 hippocampal neurons revealed by integrated miRNA and mRNA "omics". | Ecotoxicol Environ Saf | 2023 | 36841081 | PubTator, text mining | PubMed |
| Human transthyretin gene expression is markedly increased in repair Schwann cells in an in vitro model of hereditary transthyretin amyloidosis. | Neurochem Int | 2023 | 36796540 | PubTator, text mining | PubMed |
| Differentiation of Human Induced Pluripotent Stem Cells into Mature and Myelinating Schwann Cells. | Tissue Eng Part C Methods | 2023 | 36792923 | PubTator, text mining | PubMed |
| Charcot-Marie-Tooth Disease with a Novel Variant in Gap Junction Protein Beta 1 Presenting with Visual Field Defects. | Intern Med | 2023 | 36792185 | PubTator, text mining | PubMed |
| High diagnostic yield with algorithmic molecular approach on hereditary neuropathies. | Rev Assoc Med Bras (1992) | 2023 | 36790232 | PubTator, text mining | PubMed |
| The Impact of a Late Diagnosis: A Case of Charcot-Marie-Tooth Type 1. | Cureus | 2023 | 36788827 | PubTator, text mining | PubMed |
| Deep Proteome Profiling of White Adipose Tissue Reveals Marked Conservation and Distinct Features Between Different Anatomical Depots. | Mol Cell Proteomics | 2023 | 36787876 | PubTator, text mining | PubMed |
| Intravenous immunoglobulin preparations attenuate lysolecithin-induced peripheral demyelination in mice and comprise anti-large myelin protein zero antibody. | Proc Jpn Acad Ser B Phys Biol Sci | 2023 | 36775342 | PubTator, text mining | PubMed |
| Dissecting the role of cancer-associated fibroblast-derived biglycan as a potential therapeutic target in immunotherapy resistance: A tumor bulk and single-cell transcriptomic study. | Clin Transl Med | 2023 | 36772945 | PubTator, text mining | PubMed |
| Current Advances in Gene Therapies of Genetic Auditory Neuropathy Spectrum Disorder. | J Clin Med | 2023 | 36769387 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4359/papers?page=10